您当前的位置：
首页 >
文章列表页 >
Mechanism of Astragaloside Ⅳ on db/db Mice with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease Based on AMPK Signaling Pathway
更新时间：2024-02-28
|

    • Mechanism of Astragaloside Ⅳ on db/db Mice with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease Based on AMPK Signaling Pathway

      增强出版
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 5, Pages: 72-79(2024)

    • DOI：10.13422/j.cnki.syfjx.20232039    

      CLC： R2-0;R33;R289;R589.2;R575

    • Published：05 March 2024，

      Published Online：07 December 2023，

      Received：22 August 2023，

    扫 描 看 全 文

  • ZHOU Min,LIU Xiu,WU Yongjun,et al.Mechanism of Astragaloside Ⅳ on db/db Mice with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease Based on AMPK Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(05):72-79. DOI： 10.13422/j.cnki.syfjx.20232039.

  •  
  •  

0

Views

29

下载量

1

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Mechanism of Astragaloside Ⅳ in Treating Diabetic Retinopathy Based on Network Pharmacology and Molecular Docking
Molecular Mechanism of Resveratrol Against NAFLD Based on Network Pharmacology
Analysis on Mechanism of Astragali Radix in Treating IgA Nephropathy Based on Network Pharmacology and in Vitro Cell Experiment
Network Pharmacology Study of Astragaloside Ⅳ in Treatment of Ischemic Stroke

Related Author

Naixin YU
Guoqiong LI
Biao LI
Yang XU
Wen-ke QIU
Hong-mei LIANG
Yan LI
Jing-jing XIE

Related Institution

The Institute of Medicinal Plant Development，Chinese Academy of Medical Sciences and Peking Union Medical College
School of Pharmacy， Guangdong Pharmaceutical University
School of Life Sciences and Biopharmaceutics，Guangdong Pharmaceutical University
School of Basic Medical Sciences，Guangzhou University of Chinese Medicine
Fudan University
0